NexImmune (United States)

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study

Christopher E. Brightling, Eugene R. Bleecker, Reynold A. Panettieri et al. · The Lancet Respiratory Medicine · 2014 · 306 citations · Full text

Advanced Lung Disease, Immunology, Clinical Trials +7

Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.

Scott Koenig, Robert M. Woods, Yambasu A. Brewah et al. · The Journal of Immunology · 1993 · 97 citations · Full text

Mhc Class, Adaptive Immune System, Hla Immunogenetics +20

A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease

Peter M.A. Calverley, Sanjay Sethi, Michelle Dawson et al. · Respiratory Research · 2017 · 91 citations · Full text

Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers

Barbara White, Francisco León, Wendy I. White et al. · Clinical Therapeutics · 2009 · 73 citations

Healthy Adult Volunteers, Safety Trials, Immunology +8

Determination of the Di-(2-Ethylhexyl) Phthalate NOAEL for Reproductive Development in the Rat: Importance of the Retention of Extra Animals to Adulthood

Chad R. Blystone, Grace E. Kissling, Jack B. Bishop et al. · Toxicological Sciences · 2010 · 67 citations · Full text